Jan 16
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|
Jan 15
|
These 2 Top Healthcare Stocks Declared Dividend Raises in 2023
|
Jan 15
|
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, Amgen and AstraZeneca
|
Jan 14
|
3 Pricey Stocks I'll Be Watching Like a Hawk in 2024
|
Jan 14
|
These 9 Stocks Are Running To Start 2024
|
Jan 14
|
Move Over, Novo Nordisk -- This Is the Pharmaceutical Company I am Most Bullish On in 2024
|
Jan 13
|
After Surging 53% in 2023, This Pharmaceutical Stock Might Be About to Crash. Here's Why I'm Probably Wrong
|
Jan 13
|
3 Unstoppable Stocks to Buy in 2024
|
Jan 12
|
Two Health Care Leaders Scale New Highs On Big Wins
|
Jan 12
|
A Weight-Loss Drug Changed My Life. Will It Solve My Problem?
|
Jan 12
|
No Evidence New Obesity Drugs Cause Suicidal Thoughts, FDA Says
|
Jan 12
|
FDA Finds No Link Between Obesity Drugs and Suicidal Thoughts
|
Jan 11
|
Weight-Loss Drugs Don’t Cause Suicidal Thoughts, FDA Says
|
Jan 11
|
Walgreens, Eli Lilly, Crypto CEOs and more: C-Suite Insights
|
Jan 11
|
40 Cities with the Lowest Life Expectancy in the US
|
Jan 11
|
UPDATE 1-Weight loss drug windfall attracts pharma companies
|
Jan 11
|
15 States With Highest Rates of Eating Disorders
|
Jan 11
|
Drugmakers plot way into obesity market with deals and development
|
Jan 11
|
Why Eli Lilly Stock Skyrocketed 59% in 2023
|
Jan 11
|
Henlius and Sermonix Announce Strategic Collaboration and Exclusive License Agreements for Novel Endocrine Therapy Lasofoxifene
|